NA-0345

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNA-0345

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionProtein kinase C inhibitors

TargetsProtein kinase C

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A

Related LinksN/A